| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |